<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="218">
  <stage>Registered</stage>
  <submitdate>18/08/2005</submitdate>
  <approvaldate>2/09/2005</approvaldate>
  <actrnumber>ACTRN12605000260628</actrnumber>
  <trial_identification>
    <studytitle>Assessment of Diabetes after Periodontal Treatment</studytitle>
    <scientifictitle>The effect of periodontal treatment and the use of a triclosan dentifrice on glycaemic control in diabetics</scientifictitle>
    <utrn />
    <trialacronym>ADAPT</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Diabetes and Periodontal Disease</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Group1- periodontal treatment + random allocation to triclosan or non triclosan toothpaste.  The response to treatment will be assessed at 2 weeks, 6 and 12 months.</interventions>
    <comparator>Group 2- periodontal treatment after treatment for Group 1 is completed + random allocation to triclosan or non-triclosan toothpaste.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>HbA1c</outcome>
      <timepoint>Measured at 6 and 12 months after treatment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>C-peptide</outcome>
      <timepoint>Measured at 6 and 12 months after treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Response to periodontal treatment + any added benefit from triclosan toothpaste</outcome>
      <timepoint>Assessed at 2 wks, 6 &amp; 12 months. </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Inflammatory markers, plaque bacteria &amp; antibodies also assessed.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>HbA1c&gt;6%, Able to give informed consent, Minimum of 12 teeth, Chronic periodontitis.</inclusivecriteria>
    <inclusiveminage>35</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnancy, Gross dental caries, Requirement of antibiotic cover for dental treatment, Anticoagulant therapy, other serious illness.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes. As participants are recruited the next envelope in the sequence is opened and the participant asssigned accordingly.</concealment>
    <sequence>Computer generated random allocation using SPSS v11. subjects were randomly allocated to equal sized treatment groups and then randomly allocated to toothpaste type within the treatment groups.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>9/01/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The University of Queensland, Oral Care Research Programme</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Australian Dental Research Fund</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Colgate Palmolive Co</fundingname>
      <fundingaddress />
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Oral Health Clinic, Logan Hospital</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The University of Queensland Medical Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>The Princess Alexandra Hospital Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Bill Westerman</name>
      <address>Level 1 Clinical Sciences Building
The Prince Charles Hospital
Rode Rd
Chermside QLD 4032</address>
      <phone>+61 7 33508300</phone>
      <fax />
      <email>m.cullinan@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Michelle Robbins</name>
      <address>c/- Cardiovascular and Periodontal Study
Team Leader - Diabetes
Logan Hospital
Cnr Loganlea &amp; Armstrong Rds
Meadowbrook QLD 4131</address>
      <phone>+61 7 32999502</phone>
      <fax />
      <email>m.cullinan@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>